On January 28, 2025, the U.S. Food and Drug Administration (FDA) approved Ozempic for use in people with type 2 diabetes and kidney disease. This approval marks an important milestone …

Doctors prescribe many different medications to treat chronic kidney disease (CKD). These medicines help maintain balance and reduce the buildup of toxins in the body when the …

Jun 7, 2024 · Originally developed for use in type 2 diabetes mellitus (T2DM), sodium–glucose co-transporter-2 (SGLT2) inhibitors demonstrated diverse cardiovascular- and kidney …

• reduce the risk of worsening of kidney disease, kidney failure, death due to cardiovascular disease, heart attack, and hospitalization for heart failure in adults with chronic kidney disease …

Pharmacologic Treatment Options for T2D with Renoprotection Two classes of newer agents for T2D have added renal benefits beyond glycemic control.

Apr 8, 2025 · To review the key updates in the 2024 KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease (CKD) and highlight the essential role …

Abstract There is currently an unmet need for effective treatment of chronic kidney disease (CKD) that slows disease progression, prevents development of end-stage kidney disease and …

Apr 1, 2025 · Although guideline-directed medical therapy (GDMT) is an evidence-based, proven approach to manage chronic kidney disease and type 2 diabetes (CKD + T2DM), adherence is …

Chronic kidney disease in type 2 diabetes (CKD in T2D) is a progressive disease that affects the kidneys of adults with type 2 diabetes. CKD involves damage to the kidneys which can result …

Management of CKD in patients with T2D aims to preserve kidney function to reduce the risk of end-stage kidney disease, CV events, and mortality. Evidence-based recommendations for …